1-5 of 5
David Ho
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translatome Reprogramming By Rocaglates in Lymphoma Induces Drug Resistance through up-Regulation of CD98hc, Activating Downstream AKT Survival Signaling

Paola Manara, Tyler A. Cunningham, J.J. David Ho, Caroline A. Coughlin, Jonathan H. Schatz
Journal: Blood
Blood (2022) 140 (Supplement 1): 8844.
https://doi.org/10.1182/blood-2022-166771
Published: 2022
Journal Articles

Sphingosine Kinase Inhibition Has Pre-Clinical Activity in Acute Lymphoblastic Leukemia,

Craig T. Wallington-Beddoe, BSc, MBBS, David Ho, BSc, Kenneth Francis Bradstock, MB, PhD, Linda J. Bendall, BSc, PhD
Journal: Blood
Blood (2011) 118 (21): 3573.
https://doi.org/10.1182/blood.V118.21.3573.3573
Published: 2011
Journal Articles

Hemostatic Properties of Infusible Trehalose-Stabilized Lyophilized Platelet Derivatives.

Keith A. Moskowitz, PhD, Josh Dee, Jason Barnidge, Ruth Sum, David Ho, PhD, Alan S. Rudolph, PhD, MBA, Cindy S. Orser, PhD
Journal: Blood
Blood (2004) 104 (11): 834.
https://doi.org/10.1182/blood.V104.11.834.834
Published: 2004
Journal Articles

Defective binding of factor XI–N248 to activated human platelets

Mao-Fu Sun, Frank A. Baglia, David Ho, Danko Martincic, Russell E. Ware, Peter N. Walsh, David Gailani
Journal: Blood
Blood (2001) 98 (1): 125–129.
https://doi.org/10.1182/blood.V98.1.125
Published: 2001
Journal Articles

Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential

David Gailani, David Ho, Mao-Fu Sun, Qiufang Cheng, Peter N. Walsh
Journal: Blood
Blood (2001) 97 (10): 3117–3122.
https://doi.org/10.1182/blood.V97.10.3117
Published: 2001